Mark Cuban’s Cost Plus to develop US-made ibogaine in HHS push
Mark Cuban Cost Plus Drug Co. will lead research teams laying the groundwork for a domestically manufactured ibogaine product, part of an HHS effort to develop the psychedelic as a potential treatment for post-traumatic stress disorder and other serious mental illnesses, including among veterans. HHS committed up to $4.9 million to the effort through the […] The post Mark Cuban’s Cost Plus to develop US-made ibogaine in HHS push appeared first on Becker's Hospital Review | Healthcare...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.